New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
August 4, 2014
07:40 EDTESRX, INSYInsys valuation could be $4 lower on Subsys exclusion, says Wells Fargo
After another research firm stated that Insys' (INSY) Subsys would be placed on Express Scripts' (ESRX) list of excluded drugs, Wells Fargo estimates that such a development could reduce Insys' valuation by about $4. The firm notes that the stock fell $4.16 on July 31 and August 1. It keeps an Outperform rating on the shares.
News For INSY;ESRX From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
June 30, 2015
08:52 EDTINSYInsys Therapeutics price target raised to $46 from $38 at Piper Jaffray
Subscribe for More Information
June 29, 2015
11:21 EDTESRXMorgan Stanley reports 5% passive stake in Express Scripts
Subscribe for More Information
June 25, 2015
11:09 EDTINSYInsys sinks after nurse pleads guilty to receiving kickbacks
Subscribe for More Information
05:48 EDTESRXStocks with implied volatility movement; SDS ESRX
Stocks with implied volatility movement; UltraShort S&P500 ProShares (SDS) 28, Express Scripts (ESRX) 27 according to iVolatility.
June 24, 2015
14:13 EDTESRXExpress Scripts July weekly volatility elevated as shares near record high
Subscribe for More Information
June 22, 2015
08:16 EDTESRXAnthem, Cigna deal would be negative for Catamaran, says Leerink
Subscribe for More Information
June 19, 2015
11:17 EDTESRXExpress Scripts calls active amid bid speculation
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use